Has Sachin Jain received payments from drug or device companies?

Yes. Drug and device makers reported $6,360 in general payments to Sachin Jain across 126 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sachin Jain did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sachin Jain come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sachin Jain

Infectious Disease · Long Island City, NYNPI 1851565840

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,989 of the $6,360 with a category attached, or 78.4%. It is spread thinly across 19 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,837 and has fallen 67.5% since, to $597 in 2025.

$6,360in general payments, 2019–2025

Across 126 payments — averaging $50.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Philips North America LLC$1K
Abbott$1K
Heartflow, Inc.$743
Cardiva Medical, Inc.$690
Boston Scientific$543
Johnson & Johnson$519
plus $1K from 13 others

What the payments were for

Travel & lodging$1,34221%
Food & beverage$4,98978%
Education$280%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Philips North America LLC	2	$1,367
Abbott	18	$1,070
Heartflow, Inc.	7	$743
Cardiva Medical, Inc.	22	$690
Boston Scientific	18	$543
Johnson & Johnson	15	$519
Corcept Therapeutics	12	$271
Stryker(2 entities)	2	$254
Angiodynamics, Inc.	8	$241
Venclose Inc.	6	$191
Aroa Biosurgery Incorporated	1	$153
Avanir Pharmaceuticals, Inc.	1	$115
Bard Peripheral Vascular, Inc.	7	$66
Polarityte, Inc.	1	$47
Shockwave Medical, Inc	2	$32
Coala Life Inc	1	$18
Amgen	1	$15
Biocompatibles, Inc.	1	$13
Melinta Therapeutics, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,360 in reported general payments places this provider in the 85th percentile of 799 infectious disease providers in New York.

See all infectious disease providers in New York →

Other infectious disease in Long Island City

Harish MoorjaniBriarcliff Manor$733K
Sorana Segal MaurerFlushing$598K
Sian JonesNew York$406K
Antonio UrbinaNew York$373K
David BekhorNew York$358K
Andre BrutusBrooklyn$303K
Stephen ThomasSyracuse$294K
Glenn TurettFlushing$253K
Genovefa PapanicolaouNew York$209K
Abhay DhandValhalla$201K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →